Cancer-related condition
MONDO:0045054A disorder either associated with an increased risk for malignant transformation (e.g., intraepithelial neoplasia, leukoplakia, dysplastic nevus, myelodysplastic syndrome) or that develops as a result of the presence of an existing malignant neoplasm (e.g., paraneoplastic syndrome).
Also known as: cancer related problem/condition, cancer-related condition, cancer-related problem or condition, oncologic complications, problem/condition, cancer related, problem/condition, cancer-related
36 clinical trials for this condition and its sub-types, 16 tagged with Cancer-related condition itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Cancer-related condition
-
Paraneoplastic syndrome 1 trial · 20 incl. sub-types
8 sub-types
- Paraneoplastic neurologic syndrome 1 trial · 15 incl. sub-types Sub-types →
- Parneoplastic endocrine syndrome 0 trials · 11 incl. sub-types Sub-types →
- Paraneoplastic hematological syndrome 0 trials · 9 incl. sub-types Sub-types →
- Paraneoplastic renal syndrome 0 trials · 3 incl. sub-types Sub-types →
- Bilateral diffuse uveal melanocytic proliferation disease 0 trials
- Paraneoplastic cutaneous syndrome 0 trials Sub-types →
- Paraneoplastic gastrointestinal syndrome 0 trials
- Paraneoplastic rheumatic syndrome 0 trials
-
Gastric linitis plastica 0 trials
Most studied deeper sub-types
-
Can a Two-Drug combo tame a rare nerve and blood disorder?
Disease control CompletedThis phase II trial tests whether the combination of lenalidomide and dexamethasone can help people with POEMS syndrome, a rare blood disorder that damages nerves and causes other symptoms. Participants receive the drug combo either before local radiation or intensive treatment, …
Phase 2 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Magic mushroom therapy tested for End-of-Life distress
Symptom relief CompletedThis pilot study tested whether psilocybin (the active ingredient in magic mushrooms) combined with talk therapy could help reduce feelings of demoralization in people receiving hospice care. Fifteen terminally ill adults participated. The main goal was to see if the approach was…
Phase 2 • Sponsor: Yvan Beaussant, MD, MSci • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New App-Based workout shows promise for cancer fatigue
Symptom relief CompletedThis study looked at whether a 12-week home exercise program using mobile technology could reduce fatigue in cancer survivors. 110 adults who had finished cancer treatment or were on immunotherapy took part. Some also tried acupressure or brief mindfulness exercises. The goal was…
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
A 5-minute quiz might predict who gets severe chemo side effects
Knowledge-focused CompletedThis study looks at whether a short risk-assessment tool, called the CARG score, can predict severe side effects from chemotherapy in cancer patients aged 70 and older. Participants will answer questions about their health and daily function before starting a new chemotherapy reg…
Sponsor: RenJi Hospital • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC